Personalis Inc. (NASDAQ: PSNL)
$5.5900
-0.0100 ( -1.41% ) 12.7K
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Market Data
Open
$5.5900
Previous close
$5.6000
Volume
12.7K
Market cap
$474.28M
Day range
$5.5510 - $5.7050
52 week range
$1.1200 - $7.2000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Nov 06, 2024 |
| 4 | Insider transactions | 1 | Nov 05, 2024 |
| 8-k | 8K-related | 11 | Sep 19, 2024 |
| 4 | Insider transactions | 1 | Aug 20, 2024 |
| 8-k | 8K-related | 17 | Aug 16, 2024 |
| 8-k | 8K-related | 13 | Aug 07, 2024 |
| 10-q | Quarterly Reports | 76 | Aug 07, 2024 |
| 4 | Insider transactions | 1 | Aug 01, 2024 |
| 4 | Insider transactions | 1 | Aug 01, 2024 |
| 3 | Insider transactions | 1 | Jul 03, 2024 |